VRTX options flow: unusual options activity in Vertex Pharmaceuticals Inc.

Updated 28 September 2026, 09:54 ET

Over the last week the tape recorded 38 unusual options prints in Vertex Pharmaceuticals Inc. (VRTX), $2.5M of tracked premium, leaning bullish. Bullish premium was $934K against $662K bearish; $2.0M went into calls and $439K into puts, a put call ratio of 0.22. The largest print was $750K of VRTX 18 Dec 2026 $560 calls on 22 September 2026, swept at ask. The last session with prints, 25 September 2026, added 5 prints and $206K of premium. VRTX closed at $526.19 on 25 September 2026, up 0.7%.

This week's unusual flow

Unusual prints38
Tracked premium$2.5M
Net premium+$272K
Bullish premium$934K
Bearish premium$662K
Call premium$2.0M
Put premium$439K
P/C ratio0.22
Sweeps58%
Size over OI23
Whale prints0
High conviction12

Prints from 21 September 2026 to 25 September 2026, 5 sessions. Delayed tier: every print is shown twenty minutes after it executed, and the page is rebuilt after each session.

Net premium is bullish minus bearish premium. The put call ratio is put premium divided by call premium, weighted by money rather than by contract count. Sweeps is the share of prints executed across several exchanges at once. Read the guide: Reading the Pulse.

Largest prints of the week

DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
22 Sep 2026VRTX 18 Dec 2026 $560 callsSweep42193$750KAt askNeutralHigh conviction
23 Sep 2026VRTX 16 Oct 2026 $515 putsSweep713$113KAt askBearishHigh conviction
21 Sep 2026VRTX 16 Oct 2026 $520 callsSweep7769$88KAt askBullishHigh conviction
21 Sep 2026VRTX 17 Jun 2027 $520 callsTrade1351$83KAt bidBearish
25 Sep 2026VRTX 21 Jan 2028 $450 putsSweep2079$74KAt bidBullishNotable
21 Sep 2026VRTX 16 Oct 2026 $515 callsSweep510$70KAt askBullishHigh conviction
21 Sep 2026VRTX 16 Oct 2026 $515 callsSweep480$67KAt bidBearishHigh conviction
22 Sep 2026VRTX 16 Oct 2026 $540 callsSweep77140$67KAt askBullishNotable
21 Sep 2026VRTX 16 Oct 2026 $515 callsSweep470$63KAt askBullishHigh conviction
24 Sep 2026VRTX 18 Dec 2026 $540 callsTrade25396$63KAt askBullish
21 Sep 2026VRTX 16 Oct 2026 $515 callsSweep430$63KAt askBullishHigh conviction
21 Sep 2026VRTX 16 Oct 2026 $515 callsSweep400$55KAt askBullishHigh conviction

Size above open interest means the trade opened a position larger than everything that existed in the contract the night before. Above ask and below bid are the most aggressive executions. Read the guide: Size versus open interest.

Where the money is aimed

ExpiryPrintsPremiumCalls shareNet premium
18 Dec 20262$813K100%+$63K
16 Oct 202613$804K86%+$343K
25 Sep 20265$184K75%-$56K
21 Jan 20283$142K48%+$5K
17 Jun 20273$138K60%-$83K
19 Mar 20274$118K24%-$7K

The most premium, $813K, is aimed at the 18 Dec 2026 expiry; the nearest expiry with unusual prints is 25 Sep 2026.

A print in a contract expiring this week is a view about the next few days, often about a known event; a print months out is a different kind of statement. Read the guide: 0DTE options flow.

The last session, 25 September 2026

Prints5
Premium$206K
Net premium+$114K
P/C ratio1.01
Sweeps60%
DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
25 Sep 2026VRTX 21 Jan 2028 $450 putsSweep2079$74KAt bidBullishNotable
25 Sep 2026VRTX 2 Oct 2026 $527.50 callsTrade8310$38KAt askBullishNotable
25 Sep 2026VRTX 30 Oct 2026 $520 callsSweep172$33KAt askBullishNotable
25 Sep 2026VRTX 15 Jan 2027 $540 callsSweep10557$31KAt bidBearish
25 Sep 2026VRTX 17 Jun 2027 $560 putsTrade475$30KAt bidNeutral

Every print in VRTX with its full detail, the live tape, one tap filters and saved screeners: open VRTX in Options Sentiment Screener.

Price

Last close$526.19
Day+0.73%
1 week+3.51%
1 month-3.86%
3 months+7.09%
1 year+39.71%
52 week high$560.25
52 week low$377.02
Volume756,207
Market cap$132.4B

The live quote and the price chart sit beside the ticker's flow in the app: open VRTX in Options Sentiment Screener.

Analysts

The most recent analyst targets on file, from 11 firms, have a median of $570, 8.3% above the last close.

Calls bought at a strike above the average target are a bet that the analysts are too cautious; puts far below the price in a name they like are protection or a strong disagreement. Read the guide: Reading one ticker's flow.

About Vertex Pharmaceuticals Inc.

Exchange
Nasdaq
Sector
Health Care
Industry
Pharmaceutical Products
Headquarters
Boston, Massachusetts
Website
vrtx.com

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial.

In the same sector

Flow pages for other Health Care names in the S&P 500:

LLY Eli Lilly & Co.JNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co. Inc.UNH UnitedHealth Group Inc.TMO Thermo Fisher Scientific Inc.AMGN Amgen Inc.GILD Gilead Sciences, Inc.

Learn

The live tape for VRTX with every print's execution detail, one tap filters for calls, puts, sweeps and 0DTE, saved screeners and, for Realtime subscribers, push alerts and no delay. The same screen is in the iOS and Android apps.

Open VRTX in Options Sentiment Screener